Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy PersonalisNews DeskJuly 20, 20260 Tempus AI, a company that brings artificial intelligence to diagnostics, is growing its capabilities in oncology through a $1.5 billion…